Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

From the Experts

CUTTING-EDGE TECHNOLOGY
02/13/2023

Mark Goodwin, MD, discusses his experience using the SavvyWire to optimize TAVR procedures.

Mark Goodwin, MD, discusses his exper...
Having continuous hemodynamics differentiates the SavvyWire from the typical routine. Without having to change out a pigtail or flush a catheter, we can find out the resting gradient on the table when we are done, in real time. It is zeroed...
Having continuous hemodynamics differentiates the SavvyWire from the typical routine. Without having to change out a pigtail or flush a catheter, we can find out the resting gradient on the table when we are done, in real time. It is zeroed...
Having continuous hemodynamics...
02/13/2023
Cath Lab Digest
Original Contribution
02/01/2023

Ersan Tatli, MD1; Ali Buturak, MD2; Mehmet Bülent Vatan, MD1; Imran Kurt Ömürlü, MD3; Alper Erkin, MD4

Ersan Tatli, MD1; Ali Buturak, MD2; M...
Endovascular treatment of Buerger’s disease is challenging, which usually impedes antegrade revascularization options. We aimed to evaluate the effectiveness of transpedal retrograde approach in patients with Buerger’s disease with ambiguous...
Endovascular treatment of Buerger’s disease is challenging, which usually impedes antegrade revascularization options. We aimed to evaluate the effectiveness of transpedal retrograde approach in patients with Buerger’s disease with ambiguous...
Endovascular treatment of...
02/01/2023
Journal of Invasive Cardiology
Clinical Editor's Corner
01/23/2023

Morton J. Kern, MD, MSCAI, FACC, FAHA

Clinical Editor; Chief of Cardiology, Long Beach VA Medical Center, Long Beach, California; Professor of Medicine, University of California, Irvine Medical Center, Orange, California

Morton J. Kern, MD, MSCAI, FACC, FAHA...
I thought that the article on the variation of outcomes of cardiopulmonary resuscitation (CPR) in the cath lab was on point and that we could learn more, reflect, and improve our performance for this critical event.
I thought that the article on the variation of outcomes of cardiopulmonary resuscitation (CPR) in the cath lab was on point and that we could learn more, reflect, and improve our performance for this critical event.
I thought that the article on...
01/23/2023
Cath Lab Digest
Clinical Update
01/10/2023

Jennifer A. Tremmel, MD, MS

 

Associate Professor of Medicine (Cardiovascular Medicine), Susan P. and Riley P. Bechtel Medical Director of Women’s Heart Health, and Director, CTO Program, Stanford University Medical Center, Stanford, California

 

Jennifer A. Tremmel, MD, MS, FSCAI, can be contacted at jtremmel@stanford.edu

If you are located in the eastern half of the United States and are interested in learning more about the Microvascular Network, contact Dr. Henry via CLD's managing editor Rebecca Kapur at rkapur@hmpglobal.com. If you are located the western half of the U.S., please contact Dr. Tremmel at jtremmel@stanford.edu.

Jennifer A. Tremmel, MD, MS   Assoc...
Dr. Jennifer Tremmel discusses identifying and treating patients with ANOCA (also referred to as ischemia with nonobstructive coronary arteries [INOCA]), and her role as Co-Director of the Microvascular Network along with Dr. Tim Henry.
Dr. Jennifer Tremmel discusses identifying and treating patients with ANOCA (also referred to as ischemia with nonobstructive coronary arteries [INOCA]), and her role as Co-Director of the Microvascular Network along with Dr. Tim Henry.
Dr. Jennifer Tremmel discusses...
01/10/2023
Cath Lab Digest
Clinical Trial Update
01/03/2023

With A Farber, M Menard, K Rosenfield: The trial co-PIs talk with CLD.


Alik Farber, MD, MBA, Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery and Radiology at Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts;

 

Matthew Menard, MD, Co-Director of the Endovascular Surgery Program at Brigham and Women’s Hospital; Associate Professor of Surgery, Harvard Medical School, Boston, Massachusetts;

 

Kenneth Rosenfield, MD, Head of the Section of Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital, Boston, Massachusetts.

With A Farber, M Menard, K Rosenfield...
Both surgical bypass and endovascular revascularization are considered standard-of-care treatment for patients with chronic limb-threatening ischemia (CLTI), but it has remained largely unknown which treatment approach leads to better...
Both surgical bypass and endovascular revascularization are considered standard-of-care treatment for patients with chronic limb-threatening ischemia (CLTI), but it has remained largely unknown which treatment approach leads to better...
Both surgical bypass and...
01/03/2023
Cath Lab Digest
Clinical Editor's Corner
01/03/2023

Morton Kern with contributions from Sam Butman, Scottsdale, Arizona: Peter Duffy, Pinehurst, South Carolina; Kirk Garratt, Newark, Delaware; Rajiv Gulati, Mayo Clinic, Rochester, Minnesota; Sandhu Gurpreet, Mayo Clinic, Rochester, Minnesota; Tim Henry, Cincinnati, Ohio; Dean Kereiakes, Cincinnati, Ohio; Ajay Kirtane, Columbia University, New York, New York; Neil Kleiman, Houston, Texas; Jeffery Moses, Columbia University, New York, New York; Srihari S. Naidu, Westchester Medical Center, Valhalla, New York; Duane Pinto, Boston, Massachusetts; David Rizik, Scottsdale, Arizona; Chris White, Ochsner Clinic, New Orleans, Louisiana; Bonnie Weiner, University of Massachusetts, Worchester, Massachusetts

Morton Kern with contributions from S...
If we don’t make changes in patient care after PCI regardless of the troponin level, is there any value in ordering it?
If we don’t make changes in patient care after PCI regardless of the troponin level, is there any value in ordering it?
If we don’t make changes in...
01/03/2023
Cath Lab Digest
Out-of-Hospital Care
12/31/2022

Timothy Dao, MD, FACC; Rikesh Patel, MD, FACC, HeartPlace, Plano, Texas

Timothy Dao, MD, FACC; Rikesh Patel, ...
CLD talks with Timothy Dao, MD, FACC, and Rikesh Patel, MD, FACC about their practice and the best-in-class technology they utilize to provide high-quality cardiac care.
CLD talks with Timothy Dao, MD, FACC, and Rikesh Patel, MD, FACC about their practice and the best-in-class technology they utilize to provide high-quality cardiac care.
CLD talks with Timothy Dao, MD,...
12/31/2022
Cath Lab Digest
Clinical Editor's Corner
12/02/2022

Morton J. Kern, MD, MSCAI, FACC, FAHA

Clinical Editor; Chief of Cardiology, Long Beach VA Medical Center, Long Beach, California; Professor of Medicine, University of California, Irvine Medical Center, Orange, California

Morton J. Kern, MD, MSCAI, FACC, FAHA...
Working in the cardiac cath lab (or any medical unit) is a team sport. To improve efficiency and safety in the lab, team members attended a Cultural Team Training.
Working in the cardiac cath lab (or any medical unit) is a team sport. To improve efficiency and safety in the lab, team members attended a Cultural Team Training.
Working in the cardiac cath lab...
12/02/2022
Cath Lab Digest
Acute Venous Intervention
12/01/2022

CLD talks with Michael Lichtenberg, MD, FESC

Chief Medical Officer, Angiology Department, Vascular Centre Clinic, Arnsberg, Germany

CLD talks with Michael Lichtenberg, M...
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage of the Aspirex™ Thrombectomy System is its simplicity. You can just turn it on and aspirate the thrombus out. 
I think the greatest advantage...
12/01/2022
Cath Lab Digest
Clinical Update
12/01/2022

CLD talks with:

• ARCH Trial Senior Investigator Professor R. H. Stables, MA (Cantab) DM Oxon BM BCh (Oxon) FRCP (London);

• STAT2 Trial Principal Investigators Jordan G. Safirstein, MD, and Arnold H. Seto, MD, MPA.

CLD talks with: • ARCH Trial Senior ...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve...
12/01/2022
Cath Lab Digest

Advertisement

Advertisement

Advertisement